---
category: news
title: "SRI International and Exscientia Enter Collaboration to Accelerate Drug Discovery Through Automation and Artificial Intelligence"
excerpt: "Exscientia, a clinical-stage Artificial Intelligence (AI) drug-discovery company and SRI International (SRI), a research center headquartered in Menlo Park, California announced today that the companies have entered into a drug-discovery collaboration agreement to implement a new approach to drug discovery by integrating AI design with automated compound synthesis."
publishedDateTime: 2020-05-05T12:30:00Z
webUrl: "https://markets.businessinsider.com/news/stocks/sri-international-and-exscientia-enter-collaboration-to-accelerate-drug-discovery-through-automation-and-artificial-intelligence-1029165479"
type: article
quality: 18
heat: 18
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://smartableai.github.io/artificial-intelligence/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI

secured: "LX7ggUC71eYxY9ajBVantFCDYWLH/eNQr6UxjjVaQK5k22qRhVvLjGTLnJC9gpznB6GCGxXkG2/OaPcNq2RadGAPkrj8lX2pm4H4QeS72qgO432inTT5dISkpE5cxLSEIiCk3JdTRE9zBR2shhoQnN1xs9Lxw1QiqIlMhWKN0XSrgAyD/qFe7TiZzLnzq4IFxG5DvZmsTMZvmJzXO/DHPluFAEfcKpGjC4Jucz9ZYbrYiDr3C+UYrCVN/J/WI88kFdCS2wtRGFKXSiP36z3+LcgdFzy+qFcCf2691QpEWlfcPvMJ2fNzfbyvvYmEG/+S;2TuD8qlXqts7fNlx7YP6GQ=="
---

